Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Mesalamine Rectal | Mesalamine | suppository, rectal | 69918-560ANDA |
Compare
Other companies listing mesalamine
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- Allergan, Inc.7 sites · 187 NDC
- Ipca Laboratories Limited7 sites · 77 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- Matrix Pharmacorp Private Limited5 sites · 122 NDC
- Encube Ethicals Limited5 sites · 77 NDC
Enquiry
Common questions
- Is Amring Pharmaceuticals Inc. FDA approved?
- Amring Pharmaceuticals Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Amring Pharmaceuticals Inc. make?
- 1 product is listed under Amring Pharmaceuticals Inc. in the openFDA NDC Directory, most often as suppository. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.